4.6 Article

Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy

Journal

JOURNAL OF FUNGI
Volume 7, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/jof7020088

Keywords

COVID-19; mucormycosis; fungal infections; co-infections

Ask authors/readers for more resources

Viral infections can lead to ARDS and increase the risk of secondary pulmonary infections. Several studies have reported cases of severe COVID-19 complicated by secondary pulmonary aspergillosis.
Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of studies have reported on secondary pulmonary aspergillosis complicating severe COVID-19. We report the case of a 53-year old male patient with secondary acute myeloid leukemia (AML) who suffered from COVID-19 ARDS and was diagnosed postmortem with mucormycosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available